EMCURE — EMCURE PHARMACEUTICALS L

NSE · AI Signal & Stock Analysis · Bearish

As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for EMCURE is Bearish ↓ (strong move); technical trend raise-2026-07-20; trading at ₹1,862.00 (-1.44% today); neutral (RSI 56).

Data as of Aug 14 2026, 6:50 PM. Informational analytics only — not investment advice.

Key metrics

What's driving the signal

• -Near 52w High; -Strong Down
• RSI is neutral
• Relative volume 0.10× (light)
• 3% below its 52-week high
• 46% above its 52-week low

Frequently asked about EMCURE

What is AkshayaAI's signal for EMCURE today?

As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for EMCURE (EMCURE PHARMACEUTICALS L) is Bearish with a strong move, and its technical trend is raise-2026-07-20. The composite score and full factor breakdown are available to signed-in members.

Is EMCURE overbought or oversold right now?

EMCURE's RSI is neutral (RSI 56). A reading above 70 is typically overbought and below 30 oversold.

Where is EMCURE in its 52-week range?

EMCURE is trading about 3% below its 52-week high and 46% above its 52-week low as of Aug 14 2026, 6:50 PM.

What is EMCURE's market capitalisation?

EMCURE's market capitalisation is ₹36,652 Cr as of Aug 14 2026, 6:50 PM.

What sector is EMCURE in?

EMCURE is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.

AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 6:50 PM and may not reflect real-time prices. Always do your own research. How these signals work →